SHORT-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH INSULIN IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES IN SWEDEN

被引：1
|
作者：
Ridderstrale, M. [1 ,2 ]
Ericsson, A. [3 ]
Jensen, M. M. [4 ]
机构：
[1] Skane Univ Hosp, Dept Endocrinol, Malmo, Sweden
[2] Univ Lund Hosp, Dept Clin Sci, Malmo, Sweden
[3] Novo Nordisk Scandinavia AB, Malmo, Sweden
[4] Novo Nordisk Scandinavia AB, Copenhagen, Denmark
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1351
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A480 / A480
页数：1
相关论文
共 50 条
  • [1] An analysis of the cost-effectiveness of starting insulin detemir in insulin-naive people with type 2 diabetes
    Home, Philip
    Baik, Sei Hyun
    Gonzalez Galvez, Guillermo
    Malek, Rachid
    Nikolajsen, Annie
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (03) : 230 - 240
  • [2] SHORT-TERM COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR VERSUS INSULIN NEUTRAL PROTAMINE HAGEDORN (NPH) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN SPAIN
    Ramirez de Arellano, A.
    Morales, C.
    De Luis, D.
    Ferrario, M. G.
    Lizan, L.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A343 - A343
  • [3] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes
    Cheng, Huafeng
    Wan, Xu
    Ma, Jing
    Wu, Bin
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (03) : 445 - 455
  • [4] Cost-effectiveness of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients With Type 2 Diabetes Mellitus
    Brown, Stephen T.
    Grima, Daniel Grima
    Sauriol, Luc
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (11) : 1576 - 1587
  • [5] Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands
    Valentine, W. J.
    Jendle, J.
    Saraheimo, M.
    Thorsteinsson, B.
    Pollock, R. F.
    Lammert, M.
    [J]. DIABETIC MEDICINE, 2012, 29 (03) : 303 - 312
  • [6] Cost-effectiveness analysis of insulin detemir compared to NPH insulin in patients with type-2 diabetes in the United Kingdom
    Smith, I
    Palmer, AJ
    Roze, S
    Kennedy-Martin, T
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 735 - 736
  • [7] SHORT AND LONG-TERM COST-EFFECTIVENESS OF STARTING BIPHASIC INSULIN ASPART 30 IN INSULIN-NAIVE PEOPLE WITH TYPE-2 DIABETES
    Home, P. D.
    Soewondo, P.
    Hussein, Z.
    Shafie, A. A.
    AlRaddady, K.
    Baadbad, R.
    Hammerby, E.
    Nikolajsen, A.
    Andersen, M. F. B.
    Henriksen, O.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A164 - A164
  • [8] CLINICAL AND COST OUTCOMES OF TREATMENT WITH INSULIN GLARGINE VERSUS INSULIN DETEMIR IN INSULIN NAIVE TYPE 2 DIABETES PATIENTS: COST-EFFECTIVENESS ANALYSIS IN THE KAZAKHSTAN SETTING
    Kostyuk, A.
    Akanov, A.
    Almadiyeva, A.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A203 - A204
  • [9] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
    McEwan, Phil
    Poole, Chris D.
    Tetlow, Tony
    Holmes, Paul
    Currie, Craig J.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S21 - S31
  • [10] Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia
    Pedersen-Bjergaard, Ulrik
    Kristensen, Peter Lommer
    Norgaard, Kirsten
    Perrild, Hans
    Jensen, Tonny
    Thorsteinsson, Birger
    Nikolajsen, Annie
    Tarnow, Lise
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (10) : 1719 - 1725
12345